Xinxibao for the treatment of chronic bacterial prostatitis.
- Author:
Dehuai LIAO
1
;
Zhiguang CHEN
;
Zhennong DENG
;
Donghui WANG
Author Information
- Publication Type:Clinical Trial
- MeSH: Adolescent; Adult; Anti-Bacterial Agents; therapeutic use; Bacterial Infections; drug therapy; Chronic Disease; Humans; Male; Metalloproteins; therapeutic use; Microbial Sensitivity Tests; Middle Aged; Prostatitis; drug therapy; microbiology; Zinc; therapeutic use
- From:National Journal of Andrology 2004;10(9):676-677
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the effect of Xinxibao as a supplementary drug in the treatment of chronic bacterial prostatitis (CBP).
METHODSEighty-one cases of CBP were divided into two groups: Group A (n = 38), treated with Xinxibao combined with sensitive antibiotic, and Group B (n = 43), treated with sensitive antibiotic only. Contrast studies were made on the therapeutic effects in the two groups, and the results were analyzed.
RESULTSThe effectivity rate was significantly higher in Group A than in Group B.
CONCLUSIONXinxibao can effectively relieve the symptoms of CBP.
